Table 2. Socio-demographic and clinical characteristics according to antiretroviral therapy status.
| Characteristic | HAART (n = 100) | HAART-naïve (n = 100) | P value |
|---|---|---|---|
| Age in years (mean ± SD) | 40.2±8.0 | 38.0±10.6 | 0.106 |
| Married, n (%) | 52 (52%) | 37 (37%) | 0.033 |
| Waist circumference in cm (mean ± SD) | 81.9±7.5 | 78.8±7.9 | 0.004 |
| WC-defined central obesity (prevalence, %) | 40% | 27% | 0.051 |
| Hip circumference in cm (mean ± SD) | 95.3±6.6 | 92.7±9.1 | 0.021 |
| WHR (mean ± SD) | 0.86±0.07 | 0.85±0.06 | 0.333 |
| WHR-defined central obesity (prevalence, %) | 46% | 43% | 0.669 |
| Weight in Kg (mean ± SD) | 67.7±8.5 | 63.8±10.0 | 0.004 |
| Height in meters (mean ± SD) | 1.65±0.1 | 1.64±0.1 | 0.365 |
| WHtR (mean ± SD) | 0.50±0.05 | 0.48±0.05 | 0.016 |
| Elevated WHtR (WHtR > 0.5, (prevalence, %)) | 44% | 29% | 0.028 |
| BMI in Kg/m2 (mean ± SD) | 24.8±2.8 | 23.5±2.8 | 0.002 |
| BMI-defined overweight (prevalence, %) | 50% | 31% | 0.006 |
| BMI categories | 0.023 | ||
| Underweight | 1% | 1% | |
| Normal | 49% | 68% | |
| Overweight | 50% | 31% | |
| Obesity | 0% | 0% | |
| Hypertension (prevalence, %) | 38 (38%) | 19 (19%) | 0.003 |
| Time since diagnosis of HIV infection in months, median (IQR) | 68 (42–84) | 1 (1–1) | <0.001 |
| CD4 cell count in cells/μL, median (IQR), (n = 123) | 476 (361–619) | 178 (70–273) | <0.001 |
BMI–Body Mass Index, CD4—Cluster of differentiation 4, IQR–Interquartile Range, SD–Standard deviation, WC–Waist circumference, WHR–Waist-to-hip ratio, WHtR–Waist-to-height ratio.